ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Concord Medical Services Holding Ltd. ADR (CCM) Report Updated: Apr 21, 2014 | Print This Page

Get more stock ratings by Louis Navellier

Concord Medical Services Holding Ltd. ADR (CCM)

Rating: Buy Volatility: Aggressive
Total Grade: B Industry: Health Care Providers & Services
Competitors: MCK, PRSC, EXAM, AIQ

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

Concord Medical Services Holding Ltd. ADR© quotemedia

Company Profile

Concord Medical Services Holdings Limited, together with its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. The company’s services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, proton beam therapy, diagnostic imaging, and other treatment and diagnostic modalities. It offers clinical support services; develops treatment protocols for doctors; and organizes joint diagnosis between doctors in its network and clinical research. The company also operates a specialty cancer hospital, as well as leases medical and diagnostic equipment. As of March 31, 2011, it operated a network of 121 centers with 68 hospital partners that cover 46 cities and 24 provinces, and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.

Recent News: Concord Medical Services Holding Ltd. ADR